Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
Weight loss indications often face insurance coverage challenges
Recovery requires tissue repair, inflammation control, and growth factor activation working together
Ozempic is also approved to reduce the risk of heart attack, stroke or death in adults with Type 2 diabetes mellitus and known heart disease. Ozempic is a weekly injection and Rybelsus is a daily pill
Personalized Plans: Tailored to your specific needs and health goals
Medication Mechanism of Action Average Weight Loss Retatrutide Triple agonist (GLP-1, GIP, Glucagon) Up to 24% average weight loss over 48 weeks Semaglutide GLP-1 receptor agonist Up to 17% over 68 weeks Tirzepatide Dual agonist (GLP-1, GIP) Up to 25% over 52 weeks Retatrutide is used to help with weight loss
US$ 23.97
US$ 28.09
US$ 27.31
US$ 24.29
